Seeking Alpha EN

InMed Pharma gets Nasdaq non-compliance notice

Mar 27, 2026 &03122727202631; 21:12 UTC seekingalpha.com Trending 3/5

Read original on seekingalpha.com ↗

↘

Negative for markets

Sentiment score: -75/100

High impact Short-term (days)

WHAT THIS MEANS

InMed Pharma received a Nasdaq non-compliance notice, likely related to minimum bid price or listing standards. This is a company-specific negative catalyst that could trigger delisting risk and shareholder dilution.

AI CONFIDENCE

72% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

IMNM

IMNMStock

Expected to decline

Nasdaq non-compliance notice typically precedes delisting or reverse split; creates immediate selling pressure and uncertainty. Fresh news (7 min old) has not yet been fully absorbed by market.

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Short IMNM or avoid long exposure. Non-compliance notices typically result in 5-15% drops within 24h as institutional holders exit. Monitor for official delisting timeline announcement which could accelerate decline. [MOVE:-8.5%]

KEY SIGNALS

Nasdaq non-compliance notice (likely minimum bid price violation)Delisting risk or forced reverse split probabilityShareholder dilution concernsFresh catalyst with minimal market reaction windowBroad market weakness (S&P -1.67%, VIX +13%) provides bearish backdrop

SECTORS INVOLVED

HealthcarePharmaceuticalsBiotech

Analysis generated on Mar 27, 2026 at 21:20 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

InMed Pharma gets Nasdaq non-compliance notice

RELATED INTELLIGENCE